[HTML][HTML] Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
A Lugli, R Kirsch, Y Ajioka, F Bosman, G Cathomas… - Modern pathology, 2017 - Elsevier
Tumor budding is a well-established independent prognostic factor in colorectal cancer but
a standardized method for its assessment has been lacking. The primary aim of the …
a standardized method for its assessment has been lacking. The primary aim of the …
European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis
EF Stange, SPL Travis, S Vermeire… - Journal of Crohn's …, 2008 - academic.oup.com
Ulcerative colitis is a life long disease arising from an interaction between genetic and
environmental factors, but observed predominantly in the developed countries of the world …
environmental factors, but observed predominantly in the developed countries of the world …
[HTML][HTML] KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
Novel therapeutic agents targeting the epidermal growth factor receptor (EGFR) have
improved outcomes for patients with colorectal carcinoma. However, these therapies are …
improved outcomes for patients with colorectal carcinoma. However, these therapies are …
The Vienna classification of gastrointestinal epithelial neoplasia
RJ Schlemper, RH Riddell, Y Kato, F Borchard… - Gut, 2000 - gut.bmj.com
BACKGROUND Use of the conventional Western and Japanese classification systems of
gastrointestinal epithelial neoplasia results in large differences among pathologists in the …
gastrointestinal epithelial neoplasia results in large differences among pathologists in the …
[HTML][HTML] Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value
Background Colon cancer (CC) pathological staging fails to accurately predict recurrence,
and to date, no gene expression signature has proven reliable for prognosis stratification in …
and to date, no gene expression signature has proven reliable for prognosis stratification in …
[HTML][HTML] Management of epithelial precancerous conditions and lesions in the stomach (maps II): European Society of gastrointestinal endoscopy (ESGE), European …
Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …
[HTML][HTML] Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and …
T André, A De Gramont, D Vernerey… - Journal of clinical …, 2015 - folia.unifr.ch
The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the
Adjuvant Treatment of Colon Cancer) study has demonstrated 3-year disease-free survival …
Adjuvant Treatment of Colon Cancer) study has demonstrated 3-year disease-free survival …
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the …
B Terris, P Ponsot, F Paye, P Hammel… - The American journal …, 2000 - journals.lww.com
Intraductal papillary mucinous tumors (IPMTs) of the pancreas are rare tumors characterized
by a malignant potential. Because of the progress of imaging procedures, smaller cystic …
by a malignant potential. Because of the progress of imaging procedures, smaller cystic …
Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms
BN Nguyen, JF Fléjou, B Terris, J Belghiti… - The American journal …, 1999 - journals.lww.com
Atypical histologic variants of focal nodular hyperplasia have been reported and are
sometimes difficult to recognize. To characterize the morphologic spectrum of focal nodular …
sometimes difficult to recognize. To characterize the morphologic spectrum of focal nodular …
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease
L Beaugerie, M Svrcek, P Seksik, AM Bouvier, T Simon… - Gastroenterology, 2013 - Elsevier
BACKGROUND & AIMS: There is an unclear risk of colonic high-grade dysplasia (HGD) and
colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with …
colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with …